CA9 and melanoma: To investigate the release of CA-IX positive sEVs by melanoma cells in vivo, plasma samples from a pool of five late stage BRAFV600E-positive melanoma patients were processed using an anti-CA-IX-immuno-isolation method and a commercially available kit for generic EV precipitation.